Because Germany’s medical cannabis market is larger than the rest of Europe combined, so the European industry is dependent on what happens there. This could change once other large European countries legalize or further develop their already existing but too restrictive medical frameworks.
You’ll get insights on:
- Why the United Kingdom, France and Spain will be key markets in Europe in the mid- and long term.
- The current status of the domestic markets in such regions.
- The opportunities that these countries represent and how to get prepared to be a first-mover.
- How CBD is being treated by regulators
Learn more from Deepak Anand at “The Future of Cannabis and Hemp in Europe” roundtable discussion on the show floor, 2:00 p.m. Friday.